1887

n Southern African Journal of HIV Medicine - Message from the Executive

USD

 

Abstract

Fellow HIV Clinicians, by now I am sure that most of you know that the World Health Organization (WHO) issued new guidelines. One of the most important differences is that these guidelines suggest initiating HIV-positive individuals on antiretroviral therapy (ART) at a CD4+ count of 500 cells/µl. This has caused much debate. With fixed-dose combination (FDC) treatment (one pill once daily) and medications with low side-effect profiles now available, many of the arguments for delayed therapy have fallen away. However, there is no clear clinical evidence of a benefit to starting ART earlier.

Loading

Article metrics loading...

/content/m_sajhiv/14/3/EJC142385
2013-09-01
2016-12-05
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error